Aplasys was founded in 2015 as an international collaboration with a mission to bring to the market major technological innovation with computational protein expression assays.
The idea of computational protein expression was born during many years of industrial research and development by the members of the Aplasys core team and collaborators worldwide.
Fascination with the complexity and perfection of molecular biology in all living beings supported by the studies of the fundamental mechanisms of protein synthesis gave light to the computational technology that, today, is the pillar of the company’s major products and services.
Our interdisciplinary team is formed by the top business and science professionals from the biotechnology, computing, and mathematics field. We always encourage collaboration with new members that are interested in cutting-edge research and innovation.